NewODH Announces COVID-19 Therapeutics for Pharmacies
The Ohio Department of Health announced that they are expanding their oral and injectable COVID-19 therapeutic provider network to include pharmacy providers. This expansion will allow ODH to ship the Pfizer oral therapeutic Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) and Merck oral therapeutic, Molnupiravir for dispensing in pharmacies. A short onboarding process is required to receive these shipments. If your pharmacy is part of the Federal Retail Pharmacy (FRP) partnership, use this FRP COVID-19 Therapeutics Guidance Document. If your pharmacy is not part of the federal retail pharmacy network, use this Site Specific COVID-19 Therapeutics Guidance Document. Both documents contain information about enrollment, reporting, therapeutics locator, wastage management, and additional reference documents.
NewOPA COVID-19 Therapeutics Resource Survey
OPA seeks to meet your needs if your pharmacy team is interested in providing COVID-19 therapeutics. The COVID-19 therapeutics have drug-drug interactions and renal function labs to review before dispensing. Please fill out this OPA COVID-19 Therapeutics Resource Survey to give us more information on what resources would be useful for your pharmacy team.
NewMedicaid Patients Eligible for $100 Incentive for First COVID-19 Vaccine and All Booster Doses
The Ohio Department of Medicaid and Ohio’s Medicaid Managed Care Organizations (MCOs) announced continued and additional incentives for Medicaid and MyCare patients to receive their COVID-19 vaccine series and booster shots. Here is additional information:
Reminder: $100 COVID-19 Vaccine Administration Fee
ODM and Ohio’s MCOs announced that the administration fee for COVID-19 vaccines is $100 for all COVID-19 shots, including first, second, and booster doses for Medicaid members, have been extended to June 30, 2022. See further details on the https://www.covidvaxonthespot.com/providers/ Provider and Pharmacy Resources webpage. The MCO leadership encourages pharmacies to assist Medicaid patients with accessing first, second, and booster shots through phone calls, walk-in appointments, and other personalized outreach.
OPA is working diligently to facilitate communication between state decision-makers and member pharmacists. OPA has created multiple COVID-19 resources, including a COVID-19 Vaccine Information Webpage, COVID-19 Testing Hub, and COVID-19 Resources Webpage, on the OPA website www.ohiopharmacists.org under the Resources drop-down box. Please contact Myriam Shaw Ojeda, Director of Pharmacy Extension and Public Health Initiatives, for further questions at mshawojeda@ohiopharmacists.org.